By Jeffrey Ellis and Dennis Howell
Changes in technology are creating transformative opportunities for life sciences companies. Artificial intelligence is helping to streamline the drug discovery process by analyzing large data sets from clinical trials. Gene therapy promises customized, targeted patient treatment. And blockchain technology could disrupt the supply chain by allowing companies to trace drugs from manufacturer to end consumer, which could improve drug safety and provide greater visibility of drugs within the channel.